Global Bio-identical Hormone Replacement Therapy Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Bio-identical Hormone Replacement Therapy Market Insights, Forecast to 2034
Bioidentical hormone replacement therapy (BHRT) is the use of hormones that are identical on a molecular level with endogenous hormones in hormone replacement therapy.
Market Analysis and InsightsGlobal Bio-identical Hormone Replacement Therapy Market
Global Bio-identical Hormone Replacement Therapy market is expected to reach to US$ 6519 million in 2024, with a positive growth of %, compared with US$ 6205 million in 2022. Backed with the increasing demand from downstream industries, Bio-identical Hormone Replacement Therapy industry is evaluated to reach US$ 9405.5 million in 2029. The CAGR will be 6.3% during 2024 to 2029.
The growing frequency of hormonal imbalance illnesses also aids the bioidentical hormone market's expansion. The health safety of the molecule bioidentical hormone, on the other hand, acts as a market restraint. The hormonal levels discovered in a patient with a hormonal imbalance are used to create customised bioidentical hormonal replacements. Additionally, the growing R&D activities by the key players for the discovery of novel therapeutics to treat hormonal imbalances and rising product approvals are expected to aid in the growth of the studied market over the forecast period. However, the high cost of hormone replacement therapy and the risk of developing cancers with HRTs are anticipated to hamper the market growth globally. Additionally, the rise and expansion of the healthcare sector, driven by both public and private actors, particularly in developing nations, will present profitable prospects for the personal health devices market. The market growth rate is also being supported by the governmental healthcare facilities' increased adoption of bioidentical hormone replacement therapy.
Report Covers
This report presents an overview of global Bio-identical Hormone Replacement Therapy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Bio-identical Hormone Replacement Therapy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
RevitaLife
SottoPelle
JumpstartMD
BioTE Medical
Aesthetic Everything
Segment by Type
Creams
Injections
Implanted Pellets
Patches
Gels
Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Bio-identical Hormone Replacement Therapy introduction, etc. Bio-identical Hormone Replacement Therapy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Bio-identical Hormone Replacement Therapy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Market Analysis and InsightsGlobal Bio-identical Hormone Replacement Therapy Market
Global Bio-identical Hormone Replacement Therapy market is expected to reach to US$ 6519 million in 2024, with a positive growth of %, compared with US$ 6205 million in 2022. Backed with the increasing demand from downstream industries, Bio-identical Hormone Replacement Therapy industry is evaluated to reach US$ 9405.5 million in 2029. The CAGR will be 6.3% during 2024 to 2029.
The growing frequency of hormonal imbalance illnesses also aids the bioidentical hormone market's expansion. The health safety of the molecule bioidentical hormone, on the other hand, acts as a market restraint. The hormonal levels discovered in a patient with a hormonal imbalance are used to create customised bioidentical hormonal replacements. Additionally, the growing R&D activities by the key players for the discovery of novel therapeutics to treat hormonal imbalances and rising product approvals are expected to aid in the growth of the studied market over the forecast period. However, the high cost of hormone replacement therapy and the risk of developing cancers with HRTs are anticipated to hamper the market growth globally. Additionally, the rise and expansion of the healthcare sector, driven by both public and private actors, particularly in developing nations, will present profitable prospects for the personal health devices market. The market growth rate is also being supported by the governmental healthcare facilities' increased adoption of bioidentical hormone replacement therapy.
Report Covers
This report presents an overview of global Bio-identical Hormone Replacement Therapy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Bio-identical Hormone Replacement Therapy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
RevitaLife
SottoPelle
JumpstartMD
BioTE Medical
Aesthetic Everything
Segment by Type
Creams
Injections
Implanted Pellets
Patches
Gels
Segment by Application
Men
Women
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Bio-identical Hormone Replacement Therapy introduction, etc. Bio-identical Hormone Replacement Therapy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Bio-identical Hormone Replacement Therapy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices